| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/11/2004 | EP1360182B1 4-aminobenzopyran derivatives |
| 08/11/2004 | EP1358182B1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/11/2004 | EP1345614B1 Improved and stable extract from hypericum perforatum l. , method for the production thereof and its use as a topical medicament |
| 08/11/2004 | EP1324782B1 Stabilized ophthalmic hydrogen peroxide solutions |
| 08/11/2004 | EP1315708B1 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 08/11/2004 | EP1259507B1 Pseudopolymorph of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8 4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one hydrochloride |
| 08/11/2004 | EP1251846B1 C-4 carbonate taxanes |
| 08/11/2004 | EP1246641B1 Bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections |
| 08/11/2004 | EP1225904B1 Combinations of lamivudine and entecavir for treatment of hepatitis b virus infection |
| 08/11/2004 | EP1210096B1 Health food useful for preventing liver dysfunctions containing an alkanoyl l-carnitine and silybum marianum extract and its use |
| 08/11/2004 | EP1156805B1 Use of polycyclic thiazole systems for manufacturing medicaments for preventing or treating obesity |
| 08/11/2004 | EP1155003B1 Novel guanidine derivatives as inhibitors of cell adhesion |
| 08/11/2004 | EP1154988B1 Mevinolin derivatives |
| 08/11/2004 | EP1147095B1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
| 08/11/2004 | EP1143954B1 Use of nicotinic acid derivatives for the treatment of dna damage in skin cells |
| 08/11/2004 | EP1140918B1 Thrombin inhibitors |
| 08/11/2004 | EP1135381B1 Eletriptan hydrobromide monohydrate |
| 08/11/2004 | EP1135164B1 Composition for the treatment of inflammation |
| 08/11/2004 | EP1109813B1 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 08/11/2004 | EP1107965B1 Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application |
| 08/11/2004 | EP1080075B1 Piperididinyl and n-amidinopiperidinyl derivatives |
| 08/11/2004 | EP1068196B1 Nitrate salt of anti-ulcer medicine |
| 08/11/2004 | EP1056714B1 Phenylalanine derivatives as inhibitors of alpha4 integrins |
| 08/11/2004 | EP1042294B1 Heterocyclic cytotoxic agents |
| 08/11/2004 | EP1028991B1 Strictly alternating poly(alkylene oxide ether) copolymers |
| 08/11/2004 | EP1028732B1 Use of selected phytostenol esters for producing hypocholesteraemic preparations |
| 08/11/2004 | EP1019400B1 Benzo(5,6)cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors |
| 08/11/2004 | EP1014974B1 Treatment of schizophrenia and psychosis |
| 08/11/2004 | EP1012142B1 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2 |
| 08/11/2004 | EP1007516B1 Dicyclanil polymorphs and hydrates and their preparation |
| 08/11/2004 | EP1003776B1 Screening method using FREAC-11 transcription factor |
| 08/11/2004 | EP0989983B1 Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase |
| 08/11/2004 | EP0977552B1 Composition for topical application on the skin and/or its appendages comprising at least a compound containing an iminophenol fragment |
| 08/11/2004 | EP0954288B1 Solid solution of an antifungal agent with enhanced bioavailability |
| 08/11/2004 | EP0937047B1 1-arylphthalazine antagonists of excitatory amino acid receptors |
| 08/11/2004 | EP0934308B1 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| 08/11/2004 | EP0906111B1 Composition and method for treating herpes simplex |
| 08/11/2004 | EP0894135B1 Multivalent and multispecific antigen-binding protein |
| 08/11/2004 | EP0877744B1 Substituted aza- and diazacycloheptane and cyclooctane compounds and their use |
| 08/11/2004 | EP0869794B1 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
| 08/11/2004 | EP0852491B1 Use of heparinases to decrease inflammatory responses |
| 08/11/2004 | EP0805682B1 Dermatological use of vitamin d derivatives |
| 08/11/2004 | EP0804453A4 Method for detection and treatment of breast cancer |
| 08/11/2004 | EP0760657B9 Novel potent inducers of terminal differentiation and methods of use thereof |
| 08/11/2004 | EP0730648B1 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER |
| 08/11/2004 | EP0667107B1 Bifidobacterium growth promoter |
| 08/11/2004 | EP0629132B1 Purified vacuolating toxin from helicobacter pylori and methods to use same |
| 08/11/2004 | EP0604560B1 Human cyclin e |
| 08/11/2004 | EP0575464B1 Modified factor vii |
| 08/11/2004 | CN1520416A 碳水化合物衍生物 Carbohydrate derivatives |
| 08/11/2004 | CN1520415A Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for prodn. thereof and pharmaceutical compsns. contg. said derivatives |
| 08/11/2004 | CN1520414A Novel compound, its prepn. and application |
| 08/11/2004 | CN1520412A New derivatives of oxazolidinones as antibacterial agents |
| 08/11/2004 | CN1520410A Novel heteroaryl derivatives, their prepn. and use |
| 08/11/2004 | CN1520409A Piperazine oxime derivatives having Nk-1 receptor antagonistic activity |
| 08/11/2004 | CN1520408A Piperazine compounds |
| 08/11/2004 | CN1520405A Process for prepn. of racemic citalopram and/or S-or R-citalopram by separation of mixture of R-and S-citalopram |
| 08/11/2004 | CN1520404A Piperazinylpyrazines compounds as antagonists of serotonin-5-HT2 receptor |
| 08/11/2004 | CN1520403A Novel polymorph v of torasemide |
| 08/11/2004 | CN1520401A Calcilytic compounds |
| 08/11/2004 | CN1520400A Cyclic diamine compounds bearing six-membered cyclic groups |
| 08/11/2004 | CN1520325A Antitumoral formulations of thioxanthenone |
| 08/11/2004 | CN1520324A Antiangiogenic combination thereapy for treatment of cancer |
| 08/11/2004 | CN1520313A Compsns. for promoting healing of bone racture |
| 08/11/2004 | CN1520309A Methods and compsns. for treating oral and eosophagal lesions |
| 08/11/2004 | CN1520308A New application of polyphenol of natural phant as well as medication and/or health products containing polyphenol of natural plant |
| 08/11/2004 | CN1520307A Combination of Chinese traditional medicine for treating angina pectoris as well as preparation method and usage |
| 08/11/2004 | CN1520306A Methods and devices for tissure repair |
| 08/11/2004 | CN1520305A Compsns. for preparing external carbon dioxide agents |
| 08/11/2004 | CN1520304A Xenogenic oligo of or/and polyribonucleotides as agents for treatment of malignant twnours |
| 08/11/2004 | CN1520302A Method of treating hyperproliferative diseases using active vitamin D analogues |
| 08/11/2004 | CN1520301A Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
| 08/11/2004 | CN1520300A Dihydro-triterpenes in treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 08/11/2004 | CN1520299A Use of compounds with combined NEP/MP-inbihitory activity in prepan. of medicaments |
| 08/11/2004 | CN1520298A Pyrazolopyrimidines as therapeutic agents |
| 08/11/2004 | CN1520297A Sustained release drug delivery system contg. codrugs |
| 08/11/2004 | CN1520296A Amino nicotinate derivatives as glucokinase (GLK) modulators |
| 08/11/2004 | CN1520295A Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 08/11/2004 | CN1520294A Crystalline anticholinergic, method for its prodn., and use thereof in prdon of drug |
| 08/11/2004 | CN1520293A 3-flworo-pyrrolidines as antidiabetic agents |
| 08/11/2004 | CN1520292A Medicinal compsns. |
| 08/11/2004 | CN1520291A Fumaric acid derivatives as NF-Kappab inhibitors |
| 08/11/2004 | CN1520290A Carbocyclic hydrorazino inhibitors of copper-containing amine oxidases |
| 08/11/2004 | CN1520289A Method of delaying ejaculation |
| 08/11/2004 | CN1520288A Methods for prepn. and use of 1alpha, 24 (S)-dihydroxyvitamin D2 |
| 08/11/2004 | CN1520286A Gastric retention controlled drug delivery system |
| 08/11/2004 | CN1520285A Tablet comprising cetirizine and pseudoephedrine |
| 08/11/2004 | CN1520284A Anorexic compsn. comprising calcium acetate |
| 08/11/2004 | CN1520283A Control of compactability through crystallization |
| 08/11/2004 | CN1520281A Compsn. for treatment of burns |
| 08/11/2004 | CN1520261A Polybutene contg chewing gun and confection |
| 08/11/2004 | CN1519246A Salt of organic acid of cyclorrirobuxin-D, pharmaceutics and application as well as its preparation method |
| 08/11/2004 | CN1519240A Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase |
| 08/11/2004 | CN1519239A Ramification of a compound of medication as well as preparation method and application |
| 08/11/2004 | CN1519238A Technique for preparing salt of nosimidazole and combination of medication |
| 08/11/2004 | CN1519236A Compound of flavonoid as well as application and dosage form of extract product of the compound |
| 08/11/2004 | CN1519227A Zine chelated amino acid as well as its preparation and application |
| 08/11/2004 | CN1519002A Extract product of Chinese traditional medicine as well as preparation method and application |
| 08/11/2004 | CN1518987A Now usage of polyunsaturated phosphatidylcholine |
| 08/11/2004 | CN1518986A Application of isorhamnetin and its ramification in medication for treating tumor |